Diet selection and special considerations in the management of hepatic diseases

Journal of the American Veterinary Medical Association

Volumn 210, Issue 5, 1997, Pages 625-629

  Bauer, John E ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; DIET; DIET THERAPY; LIVER DISEASE; REVIEW;

ANIMAL DISEASES; ANIMAL FEED; ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; DIET; LIVER DISEASES;

EID: 0031092689     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bauer JE, Schenck PA. Nutritional management of hepatic disease. Vet Clin North Am Small Anim Pract 1989;19:513-526.
2. Strombeck LD, Schaefer MC, Rogers QR. Dietary therapy for dogs with chronic hepatic insufficiency. In: Kirk RW, ed. Current veterinary therapy VIII. Philadelphia: WB Saunders Co, 1983;817-821.
3. Lewis LD, Morris ML Jr. Gastrointestinal, pancreatic, and hepatic diseases. In: Small animal clinical nutrition. Topeka, Kan: Mark Morris Associates, 1984;48-56.
4. Donoghue S. Nutritional support of hospitalized patients. Vet Clin North Am Small Anim Pract 1989;19:475-495.
5. Kallfelz FA. Evaluation and use of pet foods: general considerations in using pet foods for adult maintenance. Vet Clin North Am Pract Vet 1989;19:387-402.
6. Scherding RG. Hepatic encephalopathy in the dog. Compend Contin Educ Pract Vet 1979;1:55-63.
7. Mortensen PB, Rasmussen HS, Holtug K. Lactulose detoxifies in vitro short-chain fatty acid production in colonic contents induced by blood: implications for hepatic coma. Gastroenterology 1988;94:750-754.
8. Aguirre A, Yoshimura N, Westman T, et al. Plasma amino acids in dogs with two experimental forms of hepatic damage. J Surg Res 1974;16:339-345.
9. Smith AR, Rossi-Fanelli F, Ziparo V, et al. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 1978;187:343-350.
10. Fisher JE, Rosen HM, Ebeid AM, et al. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976;80:77-91.
11. Condon RE. Effect of dietary protein on symptoms and survival in dogs with an Eck fistula. Am J Surg 1971;121:107-114.
12. Fischer JE, Funovics JM, Aguirre A, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975;78:276-290.
13. Schaeffer MC, Rogers QR, Buffington CA, et al. Long-term biochemical and physiologic effects of surgically placed portacaval shunts in dogs. Am J Vet Res 1986;47:346-355.
14. Schaeffer MC, Rogers QR, Leung PMB, et al. Changes in cerebrospinal fluid and plasma amino acid concentrations with elevated dietary protein concentration in dogs with portalcaval shunts. Life Sci 1991;48:2215-2223.
15. Gammal SH, Jones EA. Hepatic encephalopathy. Med Clin North Am 1989;73:793-813.
16. Tyler JW. Hepatoencephalopathy. Part II. Pathophysiology and treatment. Compend Contin Educ Pract Vet 1990;12:1260-1270.
17. Tams TR. Hepatic encephalopathy. Vet Clin North Am Small Anim Pract 1985;15:177-195.
18. Vulgamott JC. Portosystemic shunts. Vet Clin North Am Small Anim Pract 1985;15:229-242.
19. Munro HN, Fernstrom JD, Wurtman RJ. Insulin, plasma amino acid imbalance, and hepatic coma. Lancet 1975;i:722-724.
20. Roy S, Pommer-Layrargues G, Butterworth RF, et al. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology 1988;8:845-849.
21. DeBruijno KM, Blendia LM, Zilm DH, et al. Effect of dietary protein manipulation in subclinical portalsystemic encephalopathy. Gut 1983;24:53-60.
22. Weber FL Jr, Minco D, Fresard KM, et al. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology 1985;89:538-544.
23. Maddrey WC. Branched chain amino acid therapy in liver disease. J Am Coll Nutr 1985;4:639-650.
24. Naylor CD, O'Rourke K, Detsky AS, et al. Parenteral nutrition with branched chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 1989;97:1033.
25. Cerra FB, Cheung NK, Fischer JE, et al. Disease-specific amino acid infusion (FO8O) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN 1985;9:288-295.
26. Egberts EH, Schomerus H, Hamster W, et al. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology 1985;88:887-895.
27. Michel H, Bories P, Aubin JP, et al. Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. Liver 1985;5:282-289.
28. Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched-chain amino acid enrichment, in the treatment of acute alcoholic hepatitis. J Hepatol 1985;1:141-151.
29. Glynn MJ, Powell-Tuck J, Reaveley DA, et al. High lipid parenteral nutrition improves portasystemic encephalopathy. JPEN 1988;12:457-461.
30. Grungrieff K. Therapy of hepatic encephalopathy. Dtsch Z Verdau Stoffwechsellkr 1988;48:250-260.
31. Center SA. Hepatic lipidosis in the cat. Retrospective study of 150 cases, in Proceedings. 4th Annu ACVIM Vet Forum 1986;2:13/71-13/79.
32. Center SA. Feline hepatic lipidosis is a common liver disorder. Feline Health Top 1989;4:1-6.
33. Johnson GF, Sternlieb I, Twedt DC, et al. Inheritance of copper toxicosis in Bedlington Terriers. Am J Vet Res 1980;41:1865-1866.
34. Dickson ER, Fleming TR, Wiesner RH, et al. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985;312:1011-1015.
35. Lewis LD, Morris ML Jr, Hand MS. Gastrointestinal, pancreatic, and hepatic diseases. In: Small animal clinical nutrition III. Topeka, Kan: Mark Morris Associates, 1987;7-59.
36. Hill GM, Brewer GJ, Pvasod AS, et al. Oral zinc therapy for Wilson's disease patients. Clin Res 1983;31:466A.
37. Allen KGD, Twedt DC, Hunsaker HA. Tetramine cuprurectic agents: a comparison in dogs. Am J Vet Res 1987;48:28-30.
38. Twedt DC, Hunsaker HA, Allen KGD. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicoses in Bedlington Terriers. J Am Vet Med Assoc 1988;192:52-56.